![]() |
市場調查報告書
商品編碼
1470990
腹膜透析市場:按類型、產品和最終用途分類 - 2024-2030 年全球預測Peritoneal Dialysis Market by Type (Automated Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis), Product (Dialysis Solution, Peritoneal Dialysis Catheters), End Use - Global Forecast 2024-2030 |
※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。
預計2023年腹膜透析市場規模為50億美元,預計2024年將達53.3億美元,2030年將達80.3億美元,複合年成長率為7.01%。
腹膜透析是一種醫療技術,用於腎臟功能不正常時排放體內多餘的液體和廢物。此手術使用腹膜(腹腔內襯的膜)作為過濾器。在腹膜透析中,一種特殊的液體會經由導管引入腹腔以吸收廢物和多餘的液體。然後將液體排放並處理,通常一天幾次。糖尿病和高血壓等疾病的增加是慢性腎臟病的主要原因,這大大增加了腹膜透析的需求。此外,由於其便利性和成本效益,人們越來越傾向於在家中進行透析治療,從而推動了腹膜透析的採用。然而,腹膜炎的風險可能導致嚴重的併發症,這對腹膜透析提出了重大挑戰。此外,旨在提高患者舒適度和治療效果的透析解決方案和設備的創新為製造商提供了機會。利用遠端醫療對腹膜透析患者進行遠端監測可以改善患者的治療效果並擴大市場範圍。
主要市場統計 | |
---|---|
基準年[2023] | 50億美元 |
預測年份 [2024] | 53.3億美元 |
預測年份 [2030] | 80.3億美元 |
複合年成長率(%) | 7.01% |
持續的門診透析變得更加重要,因為它可以更靈活地控制透析過程。
自動腹膜透析主要使用稱為週期計的機器在夜間患者睡覺時進行透析。這種類型的透析非常適合需要彈性安排日常安排或無法全天手動進行透析的患者。另一方面,連續門診透析是不使用機器的手動透析。患者或看護者每天手動進行 4 至 5 次更改。想要保持一定程度的體力活動或無法獲得 APD 所需的可靠電力的患者通常更喜歡這種方法。
最終用途:需要更密切醫療管理的患者通常更喜歡透析中心。
透析中心是專門提供透析治療的設施,包括血液透析機和腹膜透析。透析中心是專門提供透析治療的設施,包括血液透析機和血液透析機。選擇 PD 的患者可以在這些機構接受醫療保健專業人員的直接監督和幫助。腹膜透析的居家照護環境意味著患者的住所配備了必要的腹膜透析設備和用品。居家腹膜透析無需頻繁前往透析中心或醫院,並允許根據患者的時間表進行透析治療。提供腹膜透析的醫院為處於透析初期、有多種健康狀況且需要緊急護理的患者提供服務。醫院擁有廣泛的醫療服務和設施,可全面管理患者的健康,包括帕金森氏症併發症。
區域洞察
由於其先進的醫療保健系統、強大的患者支持計劃以及對研究和專利的大量投資,美洲處於腹膜透析採用的前沿。醫療保險在其 ESRD(末期腎功能衰竭)福利下涵蓋透析,並因其成本效益而鼓勵 PD。持續創新的重點是改善透析解決方案和設備,以提高病患的安全性和便利性。在歐盟,透析的採用率正在穩步上升,儘管各國的情況有所不同。歐洲腎臟護理提供者協會 (ERCPA) 等舉措旨在標準化 PD 護理。研究投資重點是改善腹膜透析技術和減少腹膜炎。富裕的中東國家正在大力投資醫療保健,並增加對腹膜透析的興趣。另一方面,非洲國家正面臨醫療基礎設施和醫療費用的挑戰。這些區域舉措旨在透過夥伴關係和國際組織的資助來改善獲得專業發展的機會。在 ESRD 患者數量較多的亞太地區,在政府醫療改革和透析中心投資的支持下,PD 的引入進展迅速。技術創新和腹膜透析用品的本地生產使治療變得更加容易。此外,亞太地區也受惠於腹膜透析領域的強大研究舉措和技術進步。
FPNV定位矩陣
FPNV定位矩陣對於評估腹膜透析市場至關重要。我們檢視與業務策略和產品滿意度相關的關鍵指標,以對供應商進行全面評估。這種深入的分析使用戶能夠根據自己的要求做出明智的決策。根據評估,供應商被分為四個成功程度不同的像限:前沿(F)、探路者(P)、利基(N)和重要(V)。
市場佔有率分析
市場佔有率分析是一種綜合工具,可以對腹膜透析市場供應商的現狀進行深入而深入的研究。全面比較和分析供應商在整體收益、基本客群和其他關鍵指標方面的貢獻,以便更好地了解公司的績效及其在爭奪市場佔有率時面臨的挑戰。此外,該分析還提供了對該行業競爭特徵的寶貴見解,包括在研究基準年觀察到的累積、分散主導地位和合併特徵等因素。詳細程度的提高使供應商能夠做出更明智的決策並制定有效的策略,從而在市場上獲得競爭優勢。
1. 市場滲透率:提供有關主要企業所服務的市場的全面資訊。
2. 市場開拓:我們深入研究利潤豐厚的新興市場,並分析其在成熟細分市場的滲透率。
3. 市場多元化:提供有關新產品發布、開拓地區、最新發展和投資的詳細資訊。
4.競爭評估及資訊:對主要企業的市場佔有率、策略、產品、認證、監管狀況、專利狀況、製造能力等進行綜合評估。
5. 產品開發與創新:提供對未來技術、研發活動和突破性產品開發的見解。
1.腹膜透析市場規模及預測是多少?
2.腹膜透析市場預測期內需要考慮投資的產品、細分市場、應用及領域有哪些?
3. 腹膜透析市場的技術趨勢和法規結構是什麼?
4.腹膜透析市場主要廠商的市場佔有率為何?
5.進入腹膜透析市場合適的型態和策略手段是什麼?
[198 Pages Report] The Peritoneal Dialysis Market size was estimated at USD 5.00 billion in 2023 and expected to reach USD 5.33 billion in 2024, at a CAGR 7.01% to reach USD 8.03 billion by 2030.
Peritoneal dialysis is a medical technique used to draw excess fluid and waste products from the body when the kidneys are not functioning properly. This procedure employs the patient's peritoneum, a membrane lining the abdominal cavity, as a filter. During peritoneal dialysis, a special fluid is introduced into the abdominal cavity through a catheter, where it absorbs waste materials and excess fluids. The fluid is then drained and discarded, typically several times a day. An increase in conditions such as diabetes and hypertension, which are leading causes of CKD, significantly contributes to the demand for peritoneal dialysis. Additionally, there's a growing inclination towards getting dialysis treatment at home due to its convenience and cost-effectiveness, boosting the adoption of peritoneal dialysis. However, the risk of peritonitis, an infection of the peritoneum, which can lead to severe complications, poses significant challenges to peritoneal dialysis. Furthermore, innovations in dialysis solutions and devices aimed at improving patient comfort and treatment efficacy provide opportunities to the manufacturers. Leveraging telehealth for remote monitoring of peritoneal dialysis patients can improve patient outcomes and expand market reach.
KEY MARKET STATISTICS | |
---|---|
Base Year [2023] | USD 5.00 billion |
Estimated Year [2024] | USD 5.33 billion |
Forecast Year [2030] | USD 8.03 billion |
CAGR (%) | 7.01% |
Type: Increasing significance for continuous ambulatory peritoneal dialysis as it offers more flexibility and control over the dialysis process
Automated peritoneal dialysis primarily uses a machine called a cycler to perform exchanges at night while the patient sleeps. This type of dialysis is best suited for patients seeking flexibility in their daily schedule or those who are not capable of conducting manual exchanges throughout the day. Continuous ambulatory peritoneal dialysis, in contrast, is a manual dialysis method that does not require a machine. Exchanges are carried out four to five times a day, manually, by the patient or a caregiver. This modality is often preferred by patients who want to maintain a certain degree of physical activity or those who may not have access to reliable electricity needed for APD.
End Use: Patients requiring closer medical supervision often prefer dialysis centers
Dialysis Centers are facilities specifically designed to offer dialysis treatment, including both hemodialysis and peritoneal dialysis. For PD, these centers frequently serve as the initial point for education, training, and sometimes treatment. Patients opting for PD can receive direct supervision and assistance from healthcare professionals in these settings. Home care settings for peritoneal dialysis signify the patient's residence is equipped with the necessary PD equipment and supplies. Home PD allows patients to perform their dialysis treatment according to their schedule without the need to frequent a dialysis center or hospital. Hospitals offering peritoneal dialysis cater to patients who are either in the initiation phase of PD, have multiple health conditions, or require acute care management. Hospitals are equipped with a wide range of medical services and facilities for the comprehensive management of patient's health, including any complications from PD.
Regional Insights
The American region is at the forefront in terms of peritoneal dialysis adoption due to its advanced healthcare system, strong patient support programs, and significant investment in research and patents. Medicare, under the ESRD (End-Stage Renal Disease) benefit, provides coverage for dialysis, encouraging PD due to its cost-effectiveness. Ongoing innovations have focused on improving PD solutions and equipment aimed at enhancing patient safety and convenience. The EU has shown steady growth in PD adoption, with varying rates across countries. Initiatives such as the European Renal Care Providers Association (ERCPA) aim to standardize PD care. Investment in research focuses on improving PD technologies and reducing peritonitis. In wealthier Middle Eastern countries, there is significant investment in healthcare, with growing interest in peritoneal dialysis. In contrast, African countries face challenges related to healthcare infrastructure and affordability. Initiatives in these regions aim to improve access to PD through partnerships and funding from international organizations. With a large ESRD patient population, the APAC is witnessing rapid growth in PD adoption, supported by government reforms in healthcare and investment in dialysis centers. Innovations and localized production of peritoneal dialysis supplies have made the treatment more accessible. Moreover, the APAC benefits from strong research initiatives and technological advancements in peritoneal dialysis.
FPNV Positioning Matrix
The FPNV Positioning Matrix is pivotal in evaluating the Peritoneal Dialysis Market. It offers a comprehensive assessment of vendors, examining key metrics related to Business Strategy and Product Satisfaction. This in-depth analysis empowers users to make well-informed decisions aligned with their requirements. Based on the evaluation, the vendors are then categorized into four distinct quadrants representing varying levels of success: Forefront (F), Pathfinder (P), Niche (N), or Vital (V).
Market Share Analysis
The Market Share Analysis is a comprehensive tool that provides an insightful and in-depth examination of the current state of vendors in the Peritoneal Dialysis Market. By meticulously comparing and analyzing vendor contributions in terms of overall revenue, customer base, and other key metrics, we can offer companies a greater understanding of their performance and the challenges they face when competing for market share. Additionally, this analysis provides valuable insights into the competitive nature of the sector, including factors such as accumulation, fragmentation dominance, and amalgamation traits observed over the base year period studied. With this expanded level of detail, vendors can make more informed decisions and devise effective strategies to gain a competitive edge in the market.
Key Company Profiles
The report delves into recent significant developments in the Peritoneal Dialysis Market, highlighting leading vendors and their innovative profiles. These include Advin Health Care, Angiplast Pvt. Ltd., Asahi Kasei Corporation, AWAK Technologies, B. Braun SE, Baxter International Inc., Becton, Dickinson and Company, Cook Group Incorporated, DaVita Inc., Diaverum AB, Fresenius Medical Care AG & Co. KGaA, JDmeditech, JMS Co., Ltd., Medionics International Inc., Medtronic PLC, Mitra Industries, Nipro Corporation, Opterion Health AG, Renax Biomedical Technology Co., Ltd., Terumo Corporation, and Toray Industries, Inc..
Market Segmentation & Coverage
1. Market Penetration: It presents comprehensive information on the market provided by key players.
2. Market Development: It delves deep into lucrative emerging markets and analyzes the penetration across mature market segments.
3. Market Diversification: It provides detailed information on new product launches, untapped geographic regions, recent developments, and investments.
4. Competitive Assessment & Intelligence: It conducts an exhaustive assessment of market shares, strategies, products, certifications, regulatory approvals, patent landscape, and manufacturing capabilities of the leading players.
5. Product Development & Innovation: It offers intelligent insights on future technologies, R&D activities, and breakthrough product developments.
1. What is the market size and forecast of the Peritoneal Dialysis Market?
2. Which products, segments, applications, and areas should one consider investing in over the forecast period in the Peritoneal Dialysis Market?
3. What are the technology trends and regulatory frameworks in the Peritoneal Dialysis Market?
4. What is the market share of the leading vendors in the Peritoneal Dialysis Market?
5. Which modes and strategic moves are suitable for entering the Peritoneal Dialysis Market?